copyright side effects may lead to hospitalization—and Medical professionals alert that long-term impacts stay unidentifiedIf results of Lilly’s trial are favorable, the Rapid Observe designation could mean a quicker FDA approval of tirzepatide for being overweight and overweight, and possibly a speedier entry to market, the company notes in it